ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
0,00%
Bitcoin
63.898,14
0,01%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. PhaseBio Pharmaceuticals Inc (PHAS)

  7. PhaseBio Pharmaceuticals Inc (PHAS) News

PHAS

PhaseBio Pharmaceuticals (PHAS)

PhaseBio Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PHAS
DatumZeitQuelleÜberschriftSymbolFirma
30/05/202322h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
19/05/202322h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
19/05/202322h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
19/05/202322h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
19/05/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202322h23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/04/202322h06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/03/202313h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
14/02/202323h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
14/02/202321h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
14/02/202320h27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
23/12/202214h34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
21/12/202212h10Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/12/202222h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
15/11/202222h21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/11/202221h44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
31/10/202222h22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
26/10/202222h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/10/202214h00Business WirePhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy CodeNASDAQ:PHASPhaseBio Pharmaceuticals Inc
07/10/202223h22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
28/09/202218h05TipRanksPhasebio Pharmaceuticals (PHAS) was downgraded to a Hold Rating at NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
27/09/202223h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
15/08/202212h15TipRanksH.C. Wainwright Keeps Their Buy Rating on Phasebio Pharmaceuticals (PHAS)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202222h15TipRanksPhasebio Pharmaceuticals (PHAS) Receives a Buy from NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202214h34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202214h30Business WirePhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
05/07/202222h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/06/202214h18TipRanks10 Penny Stocks that Could Deliver Exponential ReturnsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/05/202223h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/05/202223h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PHAS

Kürzlich von Ihnen besucht

CCOM
SILVER
SILVER
TG
BAS
BASF
USOTC
DTEGY
Deutsche Telekom (QX)
TG
NOV
Novo Nordisk
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AAPL
Apple
NYSE
JPM
JP Morgan Chase
TG
TUI1
Tui
TG
BAYN
Bayer
NYSE
KO
Coca Cola
FX
EURGBP
Euro vs Sterling
TG
D7G
Nel ASA
USOTC
BNPQY
BNP Paribas (QX)
TG
CBK
Commerzbank
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten